## **Core Concept**
Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of HIV/AIDS. It works by inhibiting the reverse transcriptase enzyme, which is essential for the replication of the HIV virus. When combining antiretroviral drugs, it's crucial to avoid combinations that can lead to adverse effects, reduced efficacy, or increased toxicity.

## **Why the Correct Answer is Right**
Zidovudine should not be combined with Stavudine ( option **D** is not provided but based on common drug interactions). However, a well-known adverse interaction is with Stavudine due to the risk of **mitochondrial toxicity** and **lactic acidosis**, both of which are associated with NRTIs. Another critical interaction to consider is with drugs that affect its metabolism or have overlapping toxicities.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Not provided, but generally, the combination of Zidovudine with other classes of antiretroviral drugs like protease inhibitors (PIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), or entry inhibitors can be synergistic and is often used in combination therapy for HIV.
- **Option B:** Similarly, not provided, but Zidovudine can be combined with other NRTIs, though careful consideration of overlapping toxicities is necessary.
- **Option C:** Without specifics, it's hard to address directly, but generally, Zidovudine can be part of combination therapy with various antiretroviral classes.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is to avoid combining Zidovudine with Stavudine due to the increased risk of **lactic acidosis** and **mitochondrial toxicity**. This combination can significantly increase the risk of these serious side effects, which can be life-threatening.

## **Correct Answer:** . Stavudine